Medications for Non Small Cell Lung Cancer

The medications listed below are related to or used in the treatment of this condition.

Select drug class

Brands and Generics

Include off-label drugs

Rx and OTC

Drug name	Rating	Reviews	Rx/OTC	Pregnancy	CSA	Alcohol
Tagrisso	7.3	38 reviews for Tagrisso to treat Non Small Cell Lung Cancer	Rx		N
Generic name: osimertinib systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Keytruda	4.6	105 reviews for Keytruda to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: pembrolizumab systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Opdivo	5.1	32 reviews for Opdivo to treat Non Small Cell Lung Cancer	Rx		N
Generic name: nivolumab systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Alimta	8.0	1 review for Alimta to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: pemetrexed systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Avastin	8.0	1 review for Avastin to treat Non Small Cell Lung Cancer	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
nivolumab	5.3	47 reviews for nivolumab to treat Non Small Cell Lung Cancer	Rx		N
Generic name: nivolumab systemic Brand name: Opdivo Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
pembrolizumab	4.8	111 reviews for pembrolizumab to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: pembrolizumab systemic Brand name: Keytruda Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Imfinzi	8.7	3 reviews for Imfinzi to treat Non Small Cell Lung Cancer	Rx		N
Generic name: durvalumab systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
durvalumab	7.5	4 reviews for durvalumab to treat Non Small Cell Lung Cancer	Rx		N
Generic name: durvalumab systemic Brand name: Imfinzi Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Iressa	8.9	8 reviews for Iressa to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: gefitinib systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
amivantamab	8.5	4 reviews for amivantamab to treat Non Small Cell Lung Cancer	Rx		N
Generic name: amivantamab systemic Brand name: Rybrevant Drug class: miscellaneous bispecific antibodies For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Enhertu	8.8	4 reviews for Enhertu to treat Non Small Cell Lung Cancer	Rx		N
Generic name: fam-trastuzumab deruxtecan systemic Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Rybrevant	8.5	4 reviews for Rybrevant to treat Non Small Cell Lung Cancer	Rx		N
Generic name: amivantamab systemic Drug class: miscellaneous bispecific antibodies For consumers: dosage, interactions, side effects For professionals: Prescribing Information
fam-trastuzumab deruxtecan	8.8	4 reviews for fam-trastuzumab deruxtecan to treat Non Small Cell Lung Cancer	Rx		N
Generic name: fam-trastuzumab deruxtecan systemic Brand name: Enhertu Drug class: HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
hyaluronidase / nivolumab	Rate	Add review	Rx		N
Generic name: hyaluronidase / nivolumab systemic Brand name: Opdivo Qvantig Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects
Opdivo Qvantig	Rate	Add review	Rx		N
Generic name: hyaluronidase / nivolumab systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
pemetrexed	9.0	2 reviews for pemetrexed to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: pemetrexed systemic Brand names: Alimta, Pemfexy, Axtle, Pemrydi RTU Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
erlotinib	8.6	41 reviews for erlotinib to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: erlotinib systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
cisplatin	Rate	Add review	Rx	D	N
Generic name: cisplatin systemic Drug class: alkylating agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
Xalkori	7.8	5 reviews for Xalkori to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: crizotinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Gemzar	9.0	2 reviews for Gemzar to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: gemcitabine systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Alecensa	9.5	2 reviews for Alecensa to treat Non Small Cell Lung Cancer	Rx		N
Generic name: alectinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Taxotere	Rate	Add review	Rx	D	N
Generic name: docetaxel systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Abraxane	1.0	1 review for Abraxane to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: paclitaxel protein-bound systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects
paclitaxel	7.0	1 review for paclitaxel to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: paclitaxel systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
Tecentriq	Rate	Add review	Rx		N
Generic name: atezolizumab systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
bevacizumab	8.0	1 review for bevacizumab to treat Non Small Cell Lung Cancer	Rx	C	N
Generic name: bevacizumab systemic Brand names: Avastin, Mvasi, Alymsys, Vegzelma, Zirabev, Avzivi, Jobevne Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Gilotrif	10	1 review for Gilotrif to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: afatinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
gemcitabine	9.0	3 reviews for gemcitabine to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: gemcitabine systemic Brand names: Gemzar, Infugem Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
osimertinib	7.5	41 reviews for osimertinib to treat Non Small Cell Lung Cancer	Rx		N
Generic name: osimertinib systemic Brand name: Tagrisso Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
gefitinib	8.9	8 reviews for gefitinib to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: gefitinib systemic Brand name: Iressa Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
crizotinib	7.3	8 reviews for crizotinib to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: crizotinib systemic Brand name: Xalkori Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
methotrexate	Rate	Add review	Rx	X	N	X
Generic name: methotrexate systemic Brand name: Trexall Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
Navelbine	Rate	Add review	Rx	D	N
Generic name: vinorelbine systemic Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Trexall	Rate	Add review	Rx	X	N	X
Generic name: methotrexate systemic Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: Prescribing Information
docetaxel	Rate	Add review	Rx	D	N
Generic name: docetaxel systemic Brand name: Taxotere Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
atezolizumab	8.5	2 reviews for atezolizumab to treat Non Small Cell Lung Cancer	Rx		N
Generic name: atezolizumab systemic Brand name: Tecentriq Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Lorbrena	Rate	Add review	Rx		N
Generic name: lorlatinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
lorlatinib	Rate	Add review	Rx		N
Generic name: lorlatinib systemic Brand name: Lorbrena Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
afatinib	7.7	3 reviews for afatinib to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: afatinib systemic Brand name: Gilotrif Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Lumakras	10	1 review for Lumakras to treat Non Small Cell Lung Cancer	Rx		N
Generic name: sotorasib systemic Drug class: miscellaneous antineoplastics For consumers: dosage, interactions, side effects For professionals: Prescribing Information
alectinib	9.5	2 reviews for alectinib to treat Non Small Cell Lung Cancer	Rx		N
Generic name: alectinib systemic Brand name: Alecensa Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
ceritinib	5.0	1 review for ceritinib to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: ceritinib systemic Brand name: Zykadia Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Cyramza	Rate	Add review	Rx	C	N
Generic name: ramucirumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
vinorelbine	Rate	Add review	Rx	D	N
Generic name: vinorelbine systemic Brand name: Navelbine Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
Alunbrig	Rate	Add review	Rx		N
Generic name: brigatinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
capecitabine Off-label	Rate	Add review	Rx	D	N
Generic name: capecitabine systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes
Zykadia	Rate	Add review	Rx	D	N
Generic name: ceritinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Retevmo	10	4 reviews for Retevmo to treat Non Small Cell Lung Cancer	Rx		N
Generic name: selpercatinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Tafinlar	Rate	Add review	Rx	D	N
Generic name: dabrafenib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
brigatinib	Rate	Add review	Rx		N
Generic name: brigatinib systemic Brand name: Alunbrig Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Mekinist	Rate	Add review	Rx	D	N
Generic name: trametinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Photofrin	Rate	Add review	Rx	C	N
Generic name: porfimer systemic Drug class: malignancy photosensitizers For consumers: dosage, interactions, side effects For professionals: Prescribing Information
necitumumab	10	1 review for necitumumab to treat Non Small Cell Lung Cancer	Rx		N
Generic name: necitumumab systemic Brand name: Portrazza Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
paclitaxel protein-bound	1.0	1 review for paclitaxel protein-bound to treat Non Small Cell Lung Cancer	Rx	D	N
Generic name: paclitaxel protein-bound systemic Brand name: Abraxane Drug class: mitotic inhibitors For consumers: dosage, interactions, side effects
ramucirumab	Rate	Add review	Rx	C	N
Generic name: ramucirumab systemic Brand name: Cyramza Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Rozlytrek	Rate	Add review	Rx		N
Generic name: entrectinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Tabrecta	8.0	1 review for Tabrecta to treat Non Small Cell Lung Cancer	Rx		N
Generic name: capmatinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Tepmetko	Rate	Add review	Rx		N
Generic name: tepotinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
tepotinib	Rate	Add review	Rx		N
Generic name: tepotinib systemic Brand name: Tepmetko Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Vizimpro	Rate	Add review	Rx		N
Generic name: dacomitinib systemic Drug class: EGFR inhibitors, HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Augtyro	Rate	Add review	Rx		N
Generic name: repotrectinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
capmatinib	8.0	1 review for capmatinib to treat Non Small Cell Lung Cancer	Rx		N
Generic name: capmatinib systemic Brand name: Tabrecta Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
cetuximab Off-label	Rate	Add review	Rx	C	N
Generic name: cetuximab systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph Off-label: Yes
cyclophosphamide	Rate	Add review	Rx	D	N
Generic name: cyclophosphamide systemic Drug class: alkylating agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information
dacomitinib	Rate	Add review	Rx		N
Generic name: dacomitinib systemic Brand name: Vizimpro Drug class: EGFR inhibitors, HER2 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Mvasi	Rate	Add review	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
porfimer	Rate	Add review	Rx	C	N
Generic name: porfimer systemic Brand name: Photofrin Drug class: malignancy photosensitizers For consumers: dosage, interactions, side effects
Portrazza	Rate	Add review	Rx		N
Generic name: necitumumab systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
selpercatinib	10	4 reviews for selpercatinib to treat Non Small Cell Lung Cancer	Rx		N
Generic name: selpercatinib systemic Brand name: Retevmo Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
trametinib	Rate	Add review	Rx	D	N
Generic name: trametinib systemic Brand name: Mekinist Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
adagrasib	Rate	Add review	Rx		N
Generic name: adagrasib systemic Brand name: Krazati Drug class: miscellaneous antineoplastics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Alymsys	Rate	Add review	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Braftovi	Rate	Add review	Rx		N
Generic name: encorafenib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
cemiplimab	Rate	Add review	Rx		N
Generic name: cemiplimab systemic Brand name: Libtayo Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
dabrafenib	Rate	Add review	Rx	D	N
Generic name: dabrafenib systemic Brand name: Tafinlar Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
entrectinib	Rate	Add review	Rx		N
Generic name: entrectinib systemic Brand name: Rozlytrek Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Gavreto	Rate	Add review	Rx		N
Generic name: pralsetinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Infugem	Rate	Add review	Rx	D	N
Generic name: gemcitabine systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects
Libtayo	Rate	Add review	Rx		N
Generic name: cemiplimab systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Mektovi	Rate	Add review	Rx		N
Generic name: binimetinib systemic Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
mobocertinib	Rate	Add review	Rx		N
Generic name: mobocertinib systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects
Pemfexy	Rate	Add review	Rx	D	N
Generic name: pemetrexed systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information
pralsetinib	Rate	Add review	Rx		N
Generic name: pralsetinib systemic Brand name: Gavreto Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
sotorasib	10	1 review for sotorasib to treat Non Small Cell Lung Cancer	Rx		N
Generic name: sotorasib systemic Brand name: Lumakras Drug class: miscellaneous antineoplastics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Vegzelma	Rate	Add review	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Zirabev	Rate	Add review	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
atezolizumab / hyaluronidase	Rate	Add review	Rx		N
Generic name: atezolizumab / hyaluronidase systemic Brand name: Tecentriq Hybreza Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects
Avzivi	Rate	Add review	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Axtle	Rate	Add review	Rx	D	N
Generic name: pemetrexed systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information
binimetinib	Rate	Add review	Rx		N
Generic name: binimetinib systemic Brand name: Mektovi Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Bizengri	Rate	Add review	Rx		N
Generic name: zenocutuzumab systemic Drug class: miscellaneous antineoplastics For consumers: dosage, interactions, side effects For professionals: Prescribing Information
encorafenib	Rate	Add review	Rx		N
Generic name: encorafenib systemic Brand name: Braftovi Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Ensacove	Rate	Add review	Rx		U
Generic name: ensartinib systemic For consumers:
ensartinib	Rate	Add review	Rx		U
Generic name: ensartinib systemic Brand name: Ensacove For consumers: For professionals: AHFS DI Monograph
Imjudo	Rate	Add review	Rx		N
Generic name: tremelimumab systemic Drug class: anti-CTLA-4 monoclonal antibodies For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Jobevne	Rate	Add review	Rx	C	N
Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage, interactions, For professionals: Prescribing Information
Krazati	Rate	Add review	Rx		N
Generic name: adagrasib systemic Drug class: miscellaneous antineoplastics For consumers: dosage, interactions, side effects For professionals: Prescribing Information
Lazcluze	Rate	Add review	Rx		N
Generic name: lazertinib systemic Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information
lazertinib	Rate	Add review	Rx		N
Generic name: lazertinib systemic Brand name: Lazcluze Drug class: EGFR inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Pemrydi RTU	Rate	Add review	Rx	D	N
Generic name: pemetrexed systemic Drug class: antimetabolites For consumers: dosage, interactions, side effects For professionals: Prescribing Information
repotrectinib	Rate	Add review	Rx		N
Generic name: repotrectinib systemic Brand name: Augtyro Drug class: multikinase inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
Tecentriq Hybreza	Rate	Add review	Rx		N
Generic name: atezolizumab / hyaluronidase systemic Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) For consumers: dosage, interactions, side effects For professionals: Prescribing Information
tremelimumab	Rate	Add review	Rx		N
Generic name: tremelimumab systemic Brand name: Imjudo Drug class: anti-CTLA-4 monoclonal antibodies For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph
zenocutuzumab	Rate	Add review	Rx		N
Generic name: zenocutuzumab systemic Brand name: Bizengri Drug class: miscellaneous antineoplastics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph

Viewing all results. Return to paging

Frequently asked questions

View more FAQ

Learn more about Non Small Cell Lung Cancer

Care guides

Legend

Rating	For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity	Activity is based on recent site visitor activity relative to other medications in the list.
Rx	Prescription only.
OTC	Over-the-counter.
Rx/OTC	Prescription or Over-the-counter.
Off-label	This medication may not be approved by the FDA for the treatment of this condition.
EUA	An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access	Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.

Pregnancy Category
A	Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C	Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D	There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N	FDA has not classified the drug.

Controlled Substances Act (CSA) Schedule
M	The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U	CSA Schedule is unknown.
N	Is not subject to the Controlled Substances Act.
1	Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2	Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3	Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4	Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5	Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.

Alcohol
X	Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Latest FDA Approvals for Non Small Cell Lung Cancer